{"success":true,"data":{"pressRelease":{"id":"62988","rtpr_id":"nACSNZHQta","ticker":"IBRX","exchange":"NASDAQ","all_tickers":["IBRX","IMM"],"title":"ImmunityBio, Inc. (IMMP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation","author":"ACCESSWIRE","published_at":"2026-06-14T15:00:03.601Z","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June\n14, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential\nclaims on behalf of purchasers of ImmunityBio, Inc. (\"ImmunityBio\" or \"the\nCompany\") (NASDAQ:IBRX). Investors who purchased ImmunityBio securities prior\nto January 19, 2026, and continue to hold to the present, are encouraged to\nobtain additional information and assist the investigation by visiting the\nfirm's site: bgandg.com/IBRX.\n(https://bgandg.com/IBRX/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=IBRX)\n(https://app.accessnewswire.com/imagelibrary/c9a49cb5-e5c2-44ac-ac1e-7ed83dcd9e5f/bronstein-gewirtz-and-grossman-llc.png)\nImmunityBio Investigation Details\n\nThe investigation concerns whether ImmunityBio and certain of its officers\nand/or directors have engaged in corporate wrongdoing.\n\nWhat's Next for ImmunityBio Investors?\n\nIf you are aware of any facts relating to this investigation or purchased\nImmunityBio shares, you can assist this investigation by visiting the firm's\nsite: bgandg.com/IBRX\n(https://bgandg.com/IBRX/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=IBRX).\nYou can also contact Peretz Bronstein or his client relations manager, Nathan\nMiller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911 (tel:+9175900911)\n\nNo Cost to ImmunityBio Investors\n\nWe, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions\non a contingency fee basis. That means we will ask the court to reimburse us\nfor out-of-pocket expenses and attorneys' fees, usually a percentage of the\ntotal recovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for ImmunityBio Securities\nInvestigation?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide.\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/immunitybio-inc.-immp-investigation-bronstein-gewirtz-and-grossm-1171007)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSNZHQta","title":"ImmunityBio, Inc. (IMMP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation","author":"ACCESSWIRE","ticker":"IBRX","created":"2026-06-14T15:00:03.601Z","tickers":["IBRX","IMM"],"exchange":"NASDAQ","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June\n14, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential\nclaims on behalf of purchasers of ImmunityBio, Inc. (\"ImmunityBio\" or \"the\nCompany\") (NASDAQ:IBRX). Investors who purchased ImmunityBio securities prior\nto January 19, 2026, and continue to hold to the present, are encouraged to\nobtain additional information and assist the investigation by visiting the\nfirm's site: bgandg.com/IBRX.\n(https://bgandg.com/IBRX/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=IBRX)\n(https://app.accessnewswire.com/imagelibrary/c9a49cb5-e5c2-44ac-ac1e-7ed83dcd9e5f/bronstein-gewirtz-and-grossman-llc.png)\nImmunityBio Investigation Details\n\nThe investigation concerns whether ImmunityBio and certain of its officers\nand/or directors have engaged in corporate wrongdoing.\n\nWhat's Next for ImmunityBio Investors?\n\nIf you are aware of any facts relating to this investigation or purchased\nImmunityBio shares, you can assist this investigation by visiting the firm's\nsite: bgandg.com/IBRX\n(https://bgandg.com/IBRX/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=IBRX).\nYou can also contact Peretz Bronstein or his client relations manager, Nathan\nMiller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911 (tel:+9175900911)\n\nNo Cost to ImmunityBio Investors\n\nWe, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions\non a contingency fee basis. That means we will ask the court to reimburse us\nfor out-of-pocket expenses and attorneys' fees, usually a percentage of the\ntotal recovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for ImmunityBio Securities\nInvestigation?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide.\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/immunitybio-inc.-immp-investigation-bronstein-gewirtz-and-grossm-1171007)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-06-14T15:00:03.659003027Z","server_sent_at_ms":1781449203659},"received_at":"2026-06-14T15:00:03.732Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/immunitybio-inc.-immp-investigation-bronstein-gewirtz-and-grossm-1171007"},"analysis":{"id":"52413","press_release_id":"62988","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Bronstein, Gewirtz & Grossman, LLC issued a solicitation notice regarding an investigation into potential securities claims against ImmunityBio.\n\nThe firm encourages investors who purchased shares prior to January 19, 2026, to contact them or visit their website to assist the investigation.\n\nThis is a routine plaintiff-firm marketing release with no new disclosure from the issuer or court action.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace","namedEntities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"ImmunityBio, Inc.","ticker":"IBRX"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Bronstein, Gewirtz & Grossman, LLC. No new disclosure from the issuer; no certified class, no settlement. Boilerplate investigation notice."},"tickerRelevance":{"others":[],"primary":"IBRX"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Bronstein, Gewirtz & Grossman, LLC issued a solicitation notice regarding an investigation into potential securities claims against ImmunityBio.\n\nThe firm encourages investors who purchased shares prior to January 19, 2026, to contact them or visit their website to assist the investigation.\n\nThis is a routine plaintiff-firm marketing release with no new disclosure from the issuer or court action.","key_figures":{},"named_entities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"ImmunityBio, Inc.","ticker":"IBRX"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-14T15:01:59.955Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":20414,"modelName":"george-droid-qwen-72b"}}